CIK 0001806310 · Non-accelerated filer<br>Smaller reporting company
Taysha Gene Therapies, Inc.
Sign in to watch- Ticker
- TSHA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 843199512
- Phone
- (214) 612-0000
- Business address
- 3000 PEGASUS PARK DRIVE, SUITE 1430, DALLAS, TX, 75247
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 7 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-10 | Nagendran Sukumar President and Head of R&D | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −41,150 | 292,855 | ||
| 2025-08-21 | Nagendran Sukumar President and Head of R&D | Sale | −57,054 | $2.85 | $163K | 1,165,289 |
| 2025-08-21 | Alam Kamran CHIEF FINANCIAL OFFICER | Sale | −54,491 | $2.85 | $155K | 1,187,603 |
| 2025-06-02 | Stalfort John A III Director | Grant or award | +56,623 | 1,155,224 | ||
| 2025-06-02 | Stalfort John A III Director | Grant or award · Stock Option (right to buy) | +113,246 | 113,246 | ||
| 2025-06-02 | Donenberg Phillip B. Director | Grant or award | +56,623 | 219,954 | ||
| 2025-06-02 | Donenberg Phillip B. Director | Grant or award · Stock Option (right to buy) | +113,246 | 113,246 | ||
| 2025-06-02 | Long Alison S Director | Grant or award | +56,623 | 105,843 | ||
| 2025-06-02 | Long Alison S Director | Grant or award · Stock Option (right to buy) | +113,246 | 113,246 | ||
| 2025-06-02 | Sepp-Lorenzino Laura Director | Grant or award | +56,623 | 105,843 | ||
| 2025-06-02 | Sepp-Lorenzino Laura Director | Grant or award · Stock Option (right to buy) | +113,246 | 113,246 | ||
| 2025-05-30 | Manning Paul B 10% owner | Purchase | +750,000 | $2.75 | $2.1M | 2,841,704 |
| 2025-03-11 | Alam Kamran CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −29,843 | $1.69 | $50K | 1,242,094 |
| 2025-01-02 | Nolan Sean P. Chief Executive Officer | Grant or award | +892,500 | 2,078,358 | ||
| 2025-01-02 | Nolan Sean P. Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +892,500 | 892,500 | ||
| 2025-01-02 | Nagendran Sukumar President and Head of R&D | Grant or award | +324,500 | 1,222,343 | ||
| 2025-01-02 | Nagendran Sukumar President and Head of R&D | Grant or award · Employee Stock Option (right to buy) | +324,500 | 324,500 | ||
| 2025-01-02 | Alam Kamran CHIEF FINANCIAL OFFICER | Grant or award | +431,000 | 1,271,937 | ||
| 2025-01-02 | Alam Kamran CHIEF FINANCIAL OFFICER | Grant or award · Employee Stock Option (right to buy) | +431,000 | 431,000 | ||
| 2024-06-27 | Manning Paul B 10% owner | Purchase | +1,333,333 | $2.25 | $3.0M | 1,333,333 |
Page 3 of 9 · 173 trades